Cholestasis in acute alcoholic liver disease

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.

Journal of viral hepatitis·2018

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy.

Journal of viral hepatitis·2016

Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.

Journal of viral hepatitis·2014

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.

Journal of viral hepatitis·2014

The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia.

Journal of viral hepatitis·2014

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.

Journal of hepatology·2013

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Analytical Method Transfer: Planning for Success: Poster Presented at PDA Week 2026.

PDA journal of pharmaceutical science and technology·2026

A synergy strategy of deep eutectic solvents and boric acid modified β-CD polymer for enhancing enantioseparation in HPLC.

Analytica chimica acta·2026

Considerations on column length in gradient elution mode: "selectivity-limited" and "efficiency limited" separations.

Journal of chromatography. A·2026

Simulation of peptide retention on dual reversed phase: strong cation exchange functionalized stationary phase gradients.

Journal of chromatography. A·2026

Fieldable Microfluidic Platform for Separation and Assay of U and Pu from Fission Samples in Environmental Matrices.

Industrial & engineering chemistry research·2026

ZICcHILIC-HRMS as a complementary approach to IC-HRMS for highly polar contaminants in water: a method-specific assessment.

Analytical and bioanalytical chemistry·2026

Related Experiment Videos

Cholestasis in acute alcoholic liver disease

Related Concept Videos

Impact of previous hepatitis B infection on the clinical outcomes from chronic hepatitis C? A population-level analysis.

A matched comparison study of hepatitis C treatment outcomes in the prison and community setting, and an analysis of the impact of prison release or transfer during therapy.

Elevated interferon-stimulated gene transcription in peripheral blood mononuclear cells occurs in patients infected with genotype 1 but not genotype 3 hepatitis C virus.

Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's Hepatitis C Action Plan.

The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia.

Extended duration therapy with pegylated interferon and ribavirin for patients with genotype 3 hepatitis C and advanced fibrosis: final results from the STEPS trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Analytical Method Transfer: Planning for Success: Poster Presented at PDA Week 2026.

A synergy strategy of deep eutectic solvents and boric acid modified β-CD polymer for enhancing enantioseparation in HPLC.

Considerations on column length in gradient elution mode: "selectivity-limited" and "efficiency limited" separations.

Simulation of peptide retention on dual reversed phase: strong cation exchange functionalized stationary phase gradients.

Fieldable Microfluidic Platform for Separation and Assay of U and Pu from Fission Samples in Environmental Matrices.

ZICcHILIC-HRMS as a complementary approach to IC-HRMS for highly polar contaminants in water: a method-specific assessment.

Related Experiment Videos

Cholestasis in acute alcoholic liver disease

Related Concept Videos

Related Articles